{
  "schemaVersion": 1,
  "id": "research-312",
  "slug": "312-what-a-three-sample-retatrutide-analysis-showed-about-labeling",
  "title": "What a three-sample retatrutide analysis showed about labeling",
  "catalogLabel": "RETA GLP-3",
  "productCollection": "https://heritagebiolabs.com/research-library/products/reta-glp-3",
  "productHandles": [
    "reta-glp-3-689",
    "reta-glp-3-690",
    "reta-glp-3-705",
    "reta-glp-3-706"
  ],
  "productUrls": [
    "https://heritagebiolabs.com/product/reta-glp-3-689",
    "https://heritagebiolabs.com/product/reta-glp-3-690",
    "https://heritagebiolabs.com/product/reta-glp-3-705",
    "https://heritagebiolabs.com/product/reta-glp-3-706"
  ],
  "readingFocus": "Methods & identity",
  "readingFocusNote": "Reading focus is a navigational tag, not an evidence grade.",
  "wordCount": 289,
  "sourceYears": [
    2026
  ],
  "paragraphs": [
    "Short chains of amino acids connected by peptide bonds are peptides. A chemical analysis can use their mass to help determine which molecule a sample contains. Retatrutide is an investigational peptide that activates the GIP, GLP-1 and glucagon receptors. The “GLP-3” wording is a catalog label. A 2026 Australian paper examined a different question from the clinical trials. Did three products submitted to an independent testing service contain the peptide and the amount described on their labels? [1, 2]",
    "The testing service received three products anonymously. A laboratory examined whether the molecular weight matched the expected value for retatrutide. It then measured the amount present. All three samples gave molecular-weight findings consistent with the expected peptide. The amounts varied substantially, from about half of the labeled amount in one sample to almost twice the label in another. This shows why identifying a molecule and checking the stated quantity are two separate laboratory tasks. [1]",
    "The paper also reported tests for certain elemental impurities. Those tests describe a different dimension of product composition. An assay for selected elements cannot describe every chemical impurity or evaluate a preparation’s sterility. Similarly, a match on a molecular-weight measurement does not verify every property relevant to clinical use. The paper reports what the tests measured and what they found for the submitted samples. [1]",
    "With only three submissions, the study cannot estimate how common label discrepancies are among all products sold as retatrutide. It directly documents variation in the samples tested. That matters when reading clinical research. The phase 3 weight outcomes were obtained with a specified material under a trial protocol. The tested retail samples were the subjects of a product analysis, and the two sets of evidence answer different questions. [1, 2]"
  ],
  "sources": [
    {
      "number": 1,
      "citation": "Timothy Piatkowski et al. Composition and Labelling Accuracy of Products Sold as Retatrutide in Australia. Drug and Alcohol Review (publication 2026-09).",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC13445994/"
    },
    {
      "number": 2,
      "citation": "Ania M. Jastreboff et al. Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of Obesity. The New England Journal of Medicine (publication 2026-09-29).",
      "url": "https://pubmed.ncbi.nlm.nih.gov/42814954/"
    }
  ],
  "canonicalUrl": "https://heritagebiolabs.com/research-library/articles/312-what-a-three-sample-retatrutide-analysis-showed-about-labeling",
  "markdownUrl": "https://heritagebiolabs.com/research-library/data/articles/312-what-a-three-sample-retatrutide-analysis-showed-about-labeling.md",
  "jsonUrl": "https://heritagebiolabs.com/research-library/data/articles/312-what-a-three-sample-retatrutide-analysis-showed-about-labeling.json",
  "provenance": {
    "sourceArchive": "Peptide Research Articles - All 82 Volumes.zip",
    "sourceArchiveSha256": "9796bec477cbe2f8017dda81c7e58260985a13bdda1f934e8eb8d0549c2cada5",
    "sourceVolume": "Peptide Research Articles 063 - RETA GLP-3 and RETA IGF-1 LR3.docx",
    "sourceArticleNumber": 312,
    "contentSha256": "bc81bb5706c61d056d4405f109f7f1d8bc948d9a7511e53052a3bc929eaebcc1",
    "statement": "Article titles, body paragraphs and numbered citations extracted without rewriting from owner-supplied Word volumes. Product mappings use exact catalog labels; reading-focus tags and excerpts are navigational metadata. No independent peer-review or comprehensive source verification is claimed."
  },
  "scope": "Educational article about published research. For research use only; not medical advice. Literature does not establish the identity, purity or activity of a purchased lot, and studies of individual components do not validate a blend."
}
